Therapeutic Drug Monitoring of Fluconazole in Critically Ill Patients
-
- STATUS
- Recruiting
-
- participants needed
- 30
-
- sponsor
- Universitaire Ziekenhuizen Leuven
Summary
This prospective study will research the exposure and its variability to fluconazole after longitudinal administration in critically ill patients
Description
An open label, monocenter pharmacokinetic study will be carried out in critically ill patients, admitted at the University Hospitals Leuven, receiving multiple dose treatment with fluconazole.
The exposure to fluconazole in the ICU cohort over multiple days of treatment will be documented. Moreover, variability and the correlating covariates that can influence the fluconazole concentration, will be determined.
Details
Condition | Critically Ill Patients |
---|---|
Age | 18years - 100years |
Treatment | Sample collection |
Clinical Study Identifier | NCT04252027 |
Sponsor | Universitaire Ziekenhuizen Leuven |
Last Modified on | 16 February 2024 |
How to participate?
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.